Almanack Investment Partners, Llc. Gilead Sciences, Inc. Transaction History

Almanack Investment Partners, Llc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $190,647 - $217,768	3,202 New	3,202 $198,000
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $282,568 - $308,746	-4,452 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $55,560 - $63,393	926 Added 26.26%	4,452 $288,000
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $199,747 - $227,603	3,526 New	3,526 $205,000
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $182,961 - $213,417	-2,820 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $43,995 - $53,635	604 Added 27.26%	2,820 $213,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $8,466 - $9,938	119 Added 5.67%	2,216 $159,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $151,214 - $179,230	2,097	2,097 $170,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

Stay updated on Almanack Investment Partners, Llc. with notifications on news.